Ollanes, John Dave .

HRN: 21-41-04  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/28/2022
06/03/2022
Ä°VT
2.25g
Q6
Pcap C

 Indication:      Type of Infection:      Compliance to guidelines: Non-compliant To Guidelines